| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-16 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.36 | 1e-09 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.25 | 8e-08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |